The Scientific World Journal

The Scientific World Journal / 2001 / Article
Special Issue

Collection of Directions in Science Articles from TheScientificWorldJOURNAL

View this Special Issue

Directions in Science | Open Access

Volume 1 |Article ID 137951 | https://doi.org/10.1100/tsw.2001.37

Lothar Steidler, "Lactococcus lactis, A Tool for the Delivery of Therapeutic Proteins Treatment of IBD", The Scientific World Journal, vol. 1, Article ID 137951, 2 pages, 2001. https://doi.org/10.1100/tsw.2001.37

Lactococcus lactis, A Tool for the Delivery of Therapeutic Proteins Treatment of IBD

Abstract

Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammatory diseases that consists of ulcerative colitis (UC), an inflammation of the large intestine, and Crohn�s disease (CD), which can affect any part of the gastrointestinal tract. IBD affects approximately 1 in every 1000 individuals in western countries. There is a marked tendency in the age of onset toward gradually younger people. IBD represents a genuine problem in public health because of the absence of etiologic treatment. The clinical image is characterized by recurrent segmental or total inflammatory involvement of the large and/or small intestine, often resulting in a chronic, unpredictable course. The symptoms of both are extremely unpleasant and impact all aspects of quality of life. They include diarrhea, abdominal pain, rectal bleeding, fever, nausea, weight loss, lethargy, and loss of appetite. If left untreated, malnutrition, dehydration, and anemia follow, which, in extreme cases, can even lead to death. Although many patients are managed successfully with conventional medical therapy, such as anti-inflammatory corticosteroid treatment, some stay refractory to treatment, most will have recurrent activity of disease, and two thirds will require surgery. Administered orally or by injection, only a fraction of the active components of most conventional drugs reaches the intended target site, the inflamed intestinal lining. This is not only an inefficient way to deliver drugs, but, more important, means that patients are often subject to a spectrum of unpleasant side effects that result from the high levels of the drugs in other, otherwise healthy tissues and organs of the body.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views77
Downloads420
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.